【Description】
FSH levels are higher in women who are menopausal making their urine a good source for extraction. Pergonal also contains leutinizing hormone (LH) which produces many effects including higher estrogen levels. So, FSH can be extracted from urine.
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Urinary Follicle Stimulating Hormone was estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2029, growing at a CAGR of % during the forecast period 2023-2029.
North American market for Urinary Follicle Stimulating Hormone was valued at $ million in 2022 and will reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Urinary Follicle Stimulating Hormone was valued at $ million in 2022 and will reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Europe market for Urinary Follicle Stimulating Hormone was valued at $ million in 2022 and will reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029..
Report Scope
This report aims to provide a comprehensive presentation of the global market for Urinary Follicle Stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urinary Follicle Stimulating Hormone.
The Urinary Follicle Stimulating Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Urinary Follicle Stimulating Hormone market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urinary Follicle Stimulating Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Urinary Follicle Stimulating Hormone segments by manufacturers, by type, by application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2023, 2024-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
IBSA
Ferring
Livzon
Segment by Type
75IU
150IU
Others
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter Two: Detailed analysis of Urinary Follicle Stimulating Hormone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger and acquisition information, etc.
Chapter Three: Sales, revenue of Urinary Follicle Stimulating Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
【Table of Contents】
1 Urinary Follicle Stimulating Hormone Market Overview
1.1 Urinary Follicle Stimulating Hormone Product Overview
1.2 Urinary Follicle Stimulating Hormone Market Segment by Type
1.2.1 75IU
1.2.2 150IU
1.2.3 Others
1.3 Global Urinary Follicle Stimulating Hormone Market Size by Type
1.3.1 Global Urinary Follicle Stimulating Hormone Market Size Overview by Type (2018-2029)
1.3.2 Global Urinary Follicle Stimulating Hormone Historic Market Size Review by Type (2018-2023)
1.3.3 Global Urinary Follicle Stimulating Hormone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Urinary Follicle Stimulating Hormone Sales Breakdown by Type (2018-2023)
1.4.2 Europe Urinary Follicle Stimulating Hormone Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Urinary Follicle Stimulating Hormone Sales Breakdown by Type (2018-2023)
1.4.4 I194 Urinary Follicle Stimulating Hormone Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Urinary Follicle Stimulating Hormone Sales Breakdown by Type (2018-2023)
2 Global Urinary Follicle Stimulating Hormone Market Competition by Company
2.1 Global Top Players by Urinary Follicle Stimulating Hormone Sales (2018-2023)
2.2 Global Top Players by Urinary Follicle Stimulating Hormone Revenue (2018-2023)
2.3 Global Top Players by Urinary Follicle Stimulating Hormone Price (2018-2023)
2.4 Global Top Manufacturers Urinary Follicle Stimulating Hormone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Urinary Follicle Stimulating Hormone Market Competitive Situation and Trends
2.5.1 Urinary Follicle Stimulating Hormone Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Urinary Follicle Stimulating Hormone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Urinary Follicle Stimulating Hormone as of 2022)
2.7 Date of Key Manufacturers Enter into Urinary Follicle Stimulating Hormone Market
2.8 Key Manufacturers Urinary Follicle Stimulating Hormone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Urinary Follicle Stimulating Hormone Status and Outlook by Region
3.1 Global Urinary Follicle Stimulating Hormone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Urinary Follicle Stimulating Hormone Historic Market Size by Region
3.2.1 Global Urinary Follicle Stimulating Hormone Sales in Volume by Region (2018-2023)
3.2.2 Global Urinary Follicle Stimulating Hormone Sales in Value by Region (2018-2023)
3.2.3 Global Urinary Follicle Stimulating Hormone Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Urinary Follicle Stimulating Hormone Forecasted Market Size by Region
3.3.1 Global Urinary Follicle Stimulating Hormone Sales in Volume by Region (2024-2029)
3.3.2 Global Urinary Follicle Stimulating Hormone Sales in Value by Region (2024-2029)
3.3.3 Global Urinary Follicle Stimulating Hormone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Urinary Follicle Stimulating Hormone by Application
4.1 Urinary Follicle Stimulating Hormone Market Segment by Application
4.1.1 Infertility Treatment
4.1.2 Assisted Reproductive Technology
4.2 Global Urinary Follicle Stimulating Hormone Market Size by Application
4.2.1 Global Urinary Follicle Stimulating Hormone Market Size Overview by Application (2018-2029)
4.2.2 Global Urinary Follicle Stimulating Hormone Historic Market Size Review by Application (2018-2023)
4.2.3 Global Urinary Follicle Stimulating Hormone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Urinary Follicle Stimulating Hormone Sales Breakdown by Application (2018-2023)
4.3.2 Europe Urinary Follicle Stimulating Hormone Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Urinary Follicle Stimulating Hormone Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Urinary Follicle Stimulating Hormone Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Urinary Follicle Stimulating Hormone Sales Breakdown by Application (2018-2023)
5 North America Urinary Follicle Stimulating Hormone by Country
5.1 North America Urinary Follicle Stimulating Hormone Historic Market Size by Country
5.1.1 North America Urinary Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Urinary Follicle Stimulating Hormone Sales in Volume by Country (2018-2023)
5.1.3 North America Urinary Follicle Stimulating Hormone Sales in Value by Country (2018-2023)
5.2 North America Urinary Follicle Stimulating Hormone Forecasted Market Size by Country
5.2.1 North America Urinary Follicle Stimulating Hormone Sales in Volume by Country (2024-2029)
5.2.2 North America Urinary Follicle Stimulating Hormone Sales in Value by Country (2024-2029)
6 Europe Urinary Follicle Stimulating Hormone by Country
6.1 Europe Urinary Follicle Stimulating Hormone Historic Market Size by Country
6.1.1 Europe Urinary Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Urinary Follicle Stimulating Hormone Sales in Volume by Country (2018-2023)
6.1.3 Europe Urinary Follicle Stimulating Hormone Sales in Value by Country (2018-2023)
6.2 Europe Urinary Follicle Stimulating Hormone Forecasted Market Size by Country
6.2.1 Europe Urinary Follicle Stimulating Hormone Sales in Volume by Country (2024-2029)
6.2.2 Europe Urinary Follicle Stimulating Hormone Sales in Value by Country (2024-2029)
7 Asia-Pacific Urinary Follicle Stimulating Hormone by Region
7.1 Asia-Pacific Urinary Follicle Stimulating Hormone Historic Market Size by Region
7.1.1 Asia-Pacific Urinary Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Urinary Follicle Stimulating Hormone Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Urinary Follicle Stimulating Hormone Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Urinary Follicle Stimulating Hormone Forecasted Market Size by Region
7.2.1 Asia-Pacific Urinary Follicle Stimulating Hormone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Urinary Follicle Stimulating Hormone Sales in Value by Region (2024-2029)
8 Latin America Urinary Follicle Stimulating Hormone by Country
8.1 Latin America Urinary Follicle Stimulating Hormone Historic Market Size by Country
8.1.1 Latin America Urinary Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Urinary Follicle Stimulating Hormone Sales in Volume by Country (2018-2023)
8.1.3 Latin America Urinary Follicle Stimulating Hormone Sales in Value by Country (2018-2023)
8.2 Latin America Urinary Follicle Stimulating Hormone Forecasted Market Size by Country
8.2.1 Latin America Urinary Follicle Stimulating Hormone Sales in Volume by Country (2024-2029)
8.2.2 Latin America Urinary Follicle Stimulating Hormone Sales in Value by Country (2024-2029)
9 Middle East and Africa Urinary Follicle Stimulating Hormone by Country
9.1 Middle East and Africa Urinary Follicle Stimulating Hormone Historic Market Size by Country
9.1.1 Middle East and Africa Urinary Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Urinary Follicle Stimulating Hormone Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Urinary Follicle Stimulating Hormone Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Urinary Follicle Stimulating Hormone Forecasted Market Size by Country
9.2.1 Middle East and Africa Urinary Follicle Stimulating Hormone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Urinary Follicle Stimulating Hormone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 IBSA
10.1.1 IBSA Company Information
10.1.2 IBSA Introduction and Business Overview
10.1.3 IBSA Urinary Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2018-2023)
10.1.4 IBSA Urinary Follicle Stimulating Hormone Products Offered
10.1.5 IBSA Recent Development
10.2 Ferring
10.2.1 Ferring Company Information
10.2.2 Ferring Introduction and Business Overview
10.2.3 Ferring Urinary Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Ferring Urinary Follicle Stimulating Hormone Products Offered
10.2.5 Ferring Recent Development
10.3 Livzon
10.3.1 Livzon Company Information
10.3.2 Livzon Introduction and Business Overview
10.3.3 Livzon Urinary Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Livzon Urinary Follicle Stimulating Hormone Products Offered
10.3.5 Livzon Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Urinary Follicle Stimulating Hormone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Urinary Follicle Stimulating Hormone Industrial Chain Analysis
11.4 Urinary Follicle Stimulating Hormone Market Dynamics
11.4.1 Urinary Follicle Stimulating Hormone Industry Trends
11.4.2 Urinary Follicle Stimulating Hormone Market Drivers
11.4.3 Urinary Follicle Stimulating Hormone Market Challenges
11.4.4 Urinary Follicle Stimulating Hormone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Urinary Follicle Stimulating Hormone Distributors
12.3 Urinary Follicle Stimulating Hormone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
【Table of Figures】
List of Tables
Table 1. Major Company of 75IU
Table 2. Major Company of 150IU
Table 3. Major Company of Others
Table 4. Global Urinary Follicle Stimulating Hormone Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Urinary Follicle Stimulating Hormone Sales by Type (2018-2023) & (K Doses)
Table 6. Global Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Type (2018-2023)
Table 7. Global Urinary Follicle Stimulating Hormone Sales by Type (2018-2023) & (US& Million)
Table 8. Global Urinary Follicle Stimulating Hormone Market Share in Value by Type (2018-2023)
Table 9. Global Urinary Follicle Stimulating Hormone Price by Type (2018-2023) & (USD/Dose)
Table 10. Global Urinary Follicle Stimulating Hormone Sales by Type (2024-2029) & (K Doses)
Table 11. Global Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Urinary Follicle Stimulating Hormone Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Urinary Follicle Stimulating Hormone Sales Market Share in Value by Type (2024-2029)
Table 14. Global Urinary Follicle Stimulating Hormone Price by Type (2024-2029) & (USD/Dose)
Table 15. North America Urinary Follicle Stimulating Hormone Sales by Type (2018-2023) & (K Doses)
Table 16. North America Urinary Follicle Stimulating Hormone Sales by Type (2018-2023) & (US$ Million)
Table 17. Europe Urinary Follicle Stimulating Hormone Sales (K Doses) by Type (2018-2023)
Table 18. Europe Urinary Follicle Stimulating Hormone Sales by Type (2018-2023) & (US$ Million)
Table 19. Asia-Pacific Urinary Follicle Stimulating Hormone Sales (K Doses) by Type (2018-2023)
Table 20. Asia-Pacific Urinary Follicle Stimulating Hormone Sales by Type (2018-2023) & (US$ Million)
Table 21. Latin America Urinary Follicle Stimulating Hormone Sales (K Doses) by Type (2018-2023)
Table 22. Latin America Urinary Follicle Stimulating Hormone Sales by Type (2018-2023) & (US$ Million)
Table 23. Middle East and Africa Urinary Follicle Stimulating Hormone Sales (K Doses) by Type (2018-2023)
Table 24. Middle East and Africa Urinary Follicle Stimulating Hormone Sales by Type (2018-2023) & (US$ Million)
Table 25. Global Urinary Follicle Stimulating Hormone Sales by Company (2018-2023) & (K Doses)
Table 26. Global Urinary Follicle Stimulating Hormone Sales Share by Company (2018-2023)
Table 27. Global Urinary Follicle Stimulating Hormone Revenue by Company (2018-2023) & (US$ Million)
Table 28. Global Urinary Follicle Stimulating Hormone Revenue Share by Company (2018-2023)
Table 29. Global Market Urinary Follicle Stimulating Hormone Price by Company (2018-2023) & (USD/Dose)
Table 30. Global Urinary Follicle Stimulating Hormone Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Urinary Follicle Stimulating Hormone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Urinary Follicle Stimulating Hormone as of 2022)
Table 33. Date of Key Manufacturers Enter into Urinary Follicle Stimulating Hormone Market
Table 34. Key Manufacturers Urinary Follicle Stimulating Hormone Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Urinary Follicle Stimulating Hormone Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Urinary Follicle Stimulating Hormone Sales by Region (2018-2023) & (K Doses)
Table 38. Global Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Region (2018-2023)
Table 39. Global Urinary Follicle Stimulating Hormone Sales by Region (2018-2023) & (US$ Million)
Table 40. Global Urinary Follicle Stimulating Hormone Sales Market Share in Value by Region (2018-2023)
Table 41. Global Urinary Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 42. Global Urinary Follicle Stimulating Hormone Sales by Region (2024-2029) & (K Doses)
Table 43. Global Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Urinary Follicle Stimulating Hormone Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Urinary Follicle Stimulating Hormone Sales Market Share in Value by Region (2024-2029)
Table 46. Global Urinary Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2029)
Table 47. Global Urinary Follicle Stimulating Hormone Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Urinary Follicle Stimulating Hormone Sales by Application (2018-2023) & (K Doses)
Table 49. Global Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Application (2018-2023)
Table 50. Global Urinary Follicle Stimulating Hormone Sales by Application (2018-2023) & (US$ Million)
Table 51. Global Urinary Follicle Stimulating Hormone Sales Market Share in Value by Application (2018-2023)
Table 52. Global Urinary Follicle Stimulating Hormone Price by Application (2018-2023) & (USD/Dose)
Table 53. Global Urinary Follicle Stimulating Hormone Sales by Application (2024-2029) & (K Doses)
Table 54. Global Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Urinary Follicle Stimulating Hormone Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Urinary Follicle Stimulating Hormone Sales Market Share in Value by Application (2024-2029)
Table 57. Global Urinary Follicle Stimulating Hormone Price by Application (2024-2029) & (USD/Dose)
Table 58. North America Urinary Follicle Stimulating Hormone Sales by Application (2018-2023) (K Doses)
Table 59. North America Urinary Follicle Stimulating Hormone Sales by Application (2018-2023) & (US$ Million)
Table 60. Europe Urinary Follicle Stimulating Hormone Sales by Application (2018-2023) (K Doses)
Table 61. Europe Urinary Follicle Stimulating Hormone Sales by Application (2018-2023) & (US$ Million)
Table 62. Asia-Pacific Urinary Follicle Stimulating Hormone Sales by Application (2018-2023) (K Doses)
Table 63. Asia-Pacific Urinary Follicle Stimulating Hormone Sales by Application (2018-2023) & (US$ Million)
Table 64. Latin America Urinary Follicle Stimulating Hormone Sales by Application (2018-2023) (K Doses)
Table 65. Latin America Urinary Follicle Stimulating Hormone Sales by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Urinary Follicle Stimulating Hormone Sales by Application (2018-2023) (K Doses)
Table 67. Middle East and Africa Urinary Follicle Stimulating Hormone Sales by Application (2018-2023) & (US$ Million)
Table 68. North America Urinary Follicle Stimulating Hormone Sales by Country (2018-2023) & (K Doses)
Table 69. North America Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Country (2018-2023)
Table 70. North America Urinary Follicle Stimulating Hormone Sales by Country (2018-2023) & (US$ Million)
Table 71. North America Urinary Follicle Stimulating Hormone Sales Market Share in Value by Country (2018-2023)
Table 72. North America Urinary Follicle Stimulating Hormone Sales by Country (2024-2029) & (K Doses)
Table 73. North America Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Urinary Follicle Stimulating Hormone Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Urinary Follicle Stimulating Hormone Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Urinary Follicle Stimulating Hormone Sales by Country (2018-2023) & (K Doses)
Table 77. Europe Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Country (2018-2023)
Table 78. Europe Urinary Follicle Stimulating Hormone Sales by Country (2018-2023) & (US$ Million)
Table 79. Europe Urinary Follicle Stimulating Hormone Sales Market Share in Value by Country (2018-2023)
Table 80. Europe Urinary Follicle Stimulating Hormone Sales by Country (2024-2029) & (K Doses)
Table 81. Europe Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Urinary Follicle Stimulating Hormone Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Urinary Follicle Stimulating Hormone Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Urinary Follicle Stimulating Hormone Sales by Region (2018-2023) & (K Doses)
Table 85. Asia-Pacific Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Region (2018-2023)
Table 86. Asia-Pacific Urinary Follicle Stimulating Hormone Sales by Region (2018-2023) & (US$ Million)
Table 87. Asia-Pacific Urinary Follicle Stimulating Hormone Sales Market Share in Value by Region (2018-2023)
Table 88. Asia-Pacific Urinary Follicle Stimulating Hormone Sales by Region (2024-2029) & (K Doses)
Table 89. Asia-Pacific Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Urinary Follicle Stimulating Hormone Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Urinary Follicle Stimulating Hormone Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Urinary Follicle Stimulating Hormone Sales by Country (2018-2023) & (K Doses)
Table 93. Latin America Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Country (2018-2023)
Table 94. Latin America Urinary Follicle Stimulating Hormone Sales by Country (2018-2023) & (US$ Million)
Table 95. Latin America Urinary Follicle Stimulating Hormone Sales Market Share in Value by Country (2018-2023)
Table 96. Latin America Urinary Follicle Stimulating Hormone Sales by Country (2024-2029) & (K Doses)
Table 97. Latin America Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Urinary Follicle Stimulating Hormone Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Urinary Follicle Stimulating Hormone Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Urinary Follicle Stimulating Hormone Sales by Country (2018-2023) & (K Doses)
Table 101. Middle East and Africa Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Country (2018-2023)
Table 102. Middle East and Africa Urinary Follicle Stimulating Hormone Sales by Country (2018-2023) & (US$ Million)
Table 103. Middle East and Africa Urinary Follicle Stimulating Hormone Sales Market Share in Value by Country (2018-2023)
Table 104. Middle East and Africa Urinary Follicle Stimulating Hormone Sales by Country (2024-2029) & (K Doses)
Table 105. Middle East and Africa Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Urinary Follicle Stimulating Hormone Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Urinary Follicle Stimulating Hormone Sales Market Share in Value by Country (2024-2029)
Table 108. IBSA Company Information
Table 109. IBSA Introduction and Business Overview
Table 110. IBSA Urinary Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 111. IBSA Urinary Follicle Stimulating Hormone Product
Table 112. IBSA Recent Development
Table 113. Ferring Company Information
Table 114. Ferring Introduction and Business Overview
Table 115. Ferring Urinary Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 116. Ferring Urinary Follicle Stimulating Hormone Product
Table 117. Ferring Recent Development
Table 118. Livzon Company Information
Table 119. Livzon Introduction and Business Overview
Table 120. Livzon Urinary Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 121. Livzon Urinary Follicle Stimulating Hormone Product
Table 122. Livzon Recent Development
Table 123. Key Raw Materials Lists
Table 124. Raw Materials Key Suppliers Lists
Table 125. Urinary Follicle Stimulating Hormone Market Trends
Table 126. Urinary Follicle Stimulating Hormone Market Drivers
Table 127. Urinary Follicle Stimulating Hormone Market Challenges
Table 128. Urinary Follicle Stimulating Hormone Market Restraints
Table 129. Urinary Follicle Stimulating Hormone Distributors List
Table 130. Urinary Follicle Stimulating Hormone Downstream Customers
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Urinary Follicle Stimulating Hormone Product Picture
Figure 2. Global Urinary Follicle Stimulating Hormone Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Urinary Follicle Stimulating Hormone Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Urinary Follicle Stimulating Hormone Sales Status and Outlook (2018-2029) & (K Doses)
Figure 5. Product Picture of 75IU
Figure 6. Global 75IU Sales YoY Growth (2018-2029) & (K Doses)
Figure 7. Product Picture of 150IU
Figure 8. Global 150IU Sales YoY Growth (2018-2029) & (K Doses)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2029) & (K Doses)
Figure 11. Global Urinary Follicle Stimulating Hormone Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Urinary Follicle Stimulating Hormone Sales Market Share by Type in 2022 & 2029
Figure 13. North America Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2022
Figure 14. North America Urinary Follicle Stimulating Hormone Sales Market Share in Value by Type in 2022
Figure 15. Europe Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2022
Figure 16. Europe Urinary Follicle Stimulating Hormone Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Urinary Follicle Stimulating Hormone Sales Market Share in Value by Type in 2022
Figure 19. Latin America Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Urinary Follicle Stimulating Hormone Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Urinary Follicle Stimulating Hormone Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Urinary Follicle Stimulating Hormone Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Urinary Follicle Stimulating Hormone Revenue in 2022
Figure 25. Urinary Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Infertility Treatment
Figure 27. Global Infertility Treatment Sales YoY Growth (2018-2029) & (K Doses)
Figure 28. Product Picture of Assisted Reproductive Technology
Figure 29. Global Assisted Reproductive Technology Sales YoY Growth (2018-2029) & (K Doses)
Figure 30. Global Urinary Follicle Stimulating Hormone Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Urinary Follicle Stimulating Hormone Sales Market Share by Application in 2022 & 2029
Figure 32. North America Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2022
Figure 33. North America Urinary Follicle Stimulating Hormone Sales Market Share in Value by Application in 2022
Figure 34. Europe Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2022
Figure 35. Europe Urinary Follicle Stimulating Hormone Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Urinary Follicle Stimulating Hormone Sales Market Share in Value by Application in 2022
Figure 38. Latin America Urinary Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Urinary Follicle Stimulating Hormone Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Urinary Follicle Stimulating Hormone Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Urinary Follicle Stimulating Hormone Manufacturing Cost Structure
Figure 43. Urinary Follicle Stimulating Hormone Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed